Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Uterine Cervical Neoplasms × Immunohistochemistry × Clear all

Status

Completed 3 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Melanoma 2 Liver Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Tobacco Use Disorder 1 Precancerous Conditions 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasm Metastasis 1 Kidney Neoplasms 1 Hodgkin Disease 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1

Interventions

Cisplatin 39 Radiotherapy 18 Brachytherapy 16 Paclitaxel 15 Carboplatin 15 Bevacizumab 6 Drug Therapy 5 toripalimab 4 camrelizumab 4 Neoadjuvant Therapy 4 Gemcitabine 4 tislelizumab 3 pembrolizumab 3 nimotuzumab 3 apatinib 3 Vaccines 3 TP protocol 3 Radiation 3 nedaplatin 2 anlotinib 2 Topotecan 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Mindfulness 2 Mass Screening 2 Interleukin-2 2 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2 Docetaxel 2 Diathermy 2 DNA Methylation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06147960 2023-11-28

EPIcol

Centre Hospitalier Universitaire de Nīmes

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡